miR-340 was shown to induce the accumulation of p27 and subsequent cell cycle arrest by targeting three negative regulators of p27: PUM1, PUM2, and SKP2, indicating that miR-340 could repress non-small cell lung cancer (NSCLC) cell proliferation 44. Here, SKP2 is linked to non-small cell lung carcinoma.